These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 23460037

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?
    Salvagno GL, Astermark J, Lippi G, Ekman M, Franchini M, Guidi GC, Berntorp E.
    Haemophilia; 2009 Jan; 15(1):290-6. PubMed ID: 19149855
    [Abstract] [Full Text] [Related]

  • 23. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C).
    Shima M, Matsumoto T, Fukuda K, Kubota Y, Tanaka I, Nishiya K, Giles AR, Yoshioka A.
    Thromb Haemost; 2002 Mar; 87(3):436-41. PubMed ID: 11916076
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Normalization of factor VIII levels in a patient with mild haemophilia A during a 35-year period.
    Mainwaring CJ, Evans J, Chana J, Lewis H.
    Haemophilia; 2006 Nov; 12(6):668-71. PubMed ID: 17083519
    [Abstract] [Full Text] [Related]

  • 28. Variation in baseline factor VIII concentration in a retrospective cohort of mild/moderate hemophilia A patients carrying identical F8 mutations.
    Loomans JI, van Velzen AS, Eckhardt CL, Peters M, Mäkipernaa A, Holmstrom M, Brons PP, Dors N, Haya S, Voorberg J, van der Bom JG, Fijnvandraat K.
    J Thromb Haemost; 2017 Feb; 15(2):246-254. PubMed ID: 27943580
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Mild hemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype.
    Trossaërt M, Regnault V, Sigaud M, Boisseau P, Fressinaud E, Lecompte T.
    J Thromb Haemost; 2008 Mar; 6(3):486-93. PubMed ID: 18047548
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Molecular genetics of hemophilia A].
    De Brasi CD, Slavutsky IR, Larripa IB.
    Medicina (B Aires); 1996 Mar; 56(5 Pt 1):509-17. PubMed ID: 9239887
    [Abstract] [Full Text] [Related]

  • 33. Factor VIII: C (FVIII: C) recovery and half-life after infusion of steam-treated high purity factor VIII concentrate in severe hemophilia A--comparison of one-stage assay, two-stage assay and a chromogenic substrate assay.
    Hellstern P, Kiehl R, Miyashita C, Schwerdt H, von Blohn G, Köhler M, Büttner M, Wenzel E.
    Thromb Haemost; 1986 Dec 15; 56(3):353-9. PubMed ID: 3105109
    [Abstract] [Full Text] [Related]

  • 34. A multicenter pharmacokinetic study of the B-domain deleted recombinant factor VIII concentrate using different assays and standards.
    Morfini M, Cinotti S, Bellatreccia A, Paladino E, Gringeri A, Mannucci PM, ReFacto-AICE Study Group.
    J Thromb Haemost; 2003 Nov 15; 1(11):2283-9. PubMed ID: 14629459
    [Abstract] [Full Text] [Related]

  • 35. Collaborative field study on the utility of a BDD factor VIII concentrate standard in the estimation of BDDr Factor VIII:C activity in hemophilic plasma using one-stage clotting assays.
    Ingerslev J, Jankowski MA, Weston SB, Charles LA, ReFacto Field Study Participants.
    J Thromb Haemost; 2004 Apr 15; 2(4):623-8. PubMed ID: 15102018
    [Abstract] [Full Text] [Related]

  • 36. [Factor VIII assays in treated hemophilia A patients].
    Lasne D, Pouplard C, Nougier C, Eschwege V, Le Cam Duchez V, Proulle V, Smahi M, Harzallah I, Voisin S, Toulon P, Sobas F, Galinat H, Flaujac C, Ternisien C, Jeanpierre E, groupe d'études de la biologie des maladies hémorragiques du Groupe français d'études de l'hémostase et la thrombose.
    Ann Biol Clin (Paris); 2019 Feb 01; 77(1):53-65. PubMed ID: 30799298
    [Abstract] [Full Text] [Related]

  • 37. Little discrepancy between one-stage and chromogenic factor VIII (FVIII)/IX assays in a large international cohort of persons with nonsevere hemophilia A and B.
    Zwagemaker AF, Kloosterman FR, Gouw SC, Boyce S, Brons P, Cnossen MH, Collins PW, Eikenboom J, Hay C, Hengeveld RCC, Jackson S, Klopper-Tol CAM, Kruip MJHA, Gorkom BL, Male C, Nieuwenhuizen L, Shapiro S, Fijnvandraat K, Coppens M, DYNAMO study group.
    J Thromb Haemost; 2023 Apr 01; 21(4):850-861. PubMed ID: 36696222
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The use of the new ReFacto AF Laboratory Standard allows reliable measurement of FVIII:C levels in ReFacto AF mock plasma samples by a one-stage clotting assay.
    Pouplard C, Caron C, Aillaud MF, Ternisien C, Desconclois C, Dubanchet A, Sobas F.
    Haemophilia; 2011 Sep 01; 17(5):e958-62. PubMed ID: 21457408
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.